首页 > 最新文献

Obstetrics and Gynecology International最新文献

英文 中文
Knowledge, Attitudes, and Practices Regarding Infertility Among Lebanese Women Experiencing Difficulty Conceiving. 黎巴嫩妇女不孕不育的知识、态度和实践。
IF 1.3 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-30 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/1745668
Reva Mosleh, Jana Kassir, Hiba Assi, Hassan Ajami, Joseph Azoury, Roula Ajrouche, Amal Al-Hajje

Background: Infertility is a significant global challenge, impacting millions of individuals across the world. In Lebanon, where fertility rates are declining, understanding the knowledge, attitudes, and practices of women experiencing infertility is vital to dispelling misconceptions, improving healthcare, and offering better support for those struggling to conceive.

Methods: A cross-sectional study was conducted between June and September 2024, involving 346 Lebanese women from two fertility centers in Beirut. Participants were randomly selected to complete the questionnaire through individual interviews. Descriptive and bivariate analyses were performed, and generalized linear models were used to explore the influencing factors for each of the knowledge, attitudes, and practice scores.

Results: The results showed that 63.6% of participants had high knowledge, 66.2% had positive attitudes, and 82.1% exhibited good practices. The generalized linear models revealed that being a healthcare provider (β = 0.663), sleeping ≥ 7 h (β = 0.409), and having a history of anxiety (β = 1.258) were associated with higher knowledge scores, while advanced female age as a cause of infertility was linked to lower knowledge (β = -0.997). For attitudes, medical insurance (β = -1.312) and a family income of 1000-2000 USD (β = -2.85) improved attitudes, while smoking (β = 3.874), history of endometrial ablation (β = 5.506), and longer marriage duration (β = 0.135) worsened them. For practices, longer marriage duration (β = 0.012) and a previous assisted reproductive technology (ART) experience (β = 0.154) improved practices, while having a history of respiratory disorder (β = -0.472) decreased practice scores.

Conclusion: This study shows that Lebanese women experiencing difficulty conceiving generally have a high level of knowledge, positive attitudes, alongside good related practices toward infertility. However, knowledge gaps and cultural factors remain, highlighting the need for enhanced reproductive health education and specialized trainings for healthcare providers.

背景:不孕症是一项重大的全球性挑战,影响着全世界数百万人。在生育率不断下降的黎巴嫩,了解不孕妇女的知识、态度和做法对于消除误解、改善医疗保健和为难以怀孕的妇女提供更好的支持至关重要。方法:一项横断面研究于2024年6月至9月进行,涉及来自贝鲁特两个生育中心的346名黎巴嫩妇女。随机选择参与者通过个人访谈完成问卷调查。进行描述性和双变量分析,并采用广义线性模型探讨知识、态度和实践得分的影响因素。结果:63.6%的参试者知识水平高,66.2%的参试者态度积极,82.1%的参试者行为良好。广义线性模型显示,作为医疗服务提供者(β = 0.663)、睡眠≥7 h (β = 0.409)和有焦虑史(β = 1.258)与较高的知识得分相关,而高龄女性作为不孕原因与较低的知识得分相关(β = -0.997)。在态度方面,医疗保险(β = -1.312)和家庭收入1000-2000美元(β = -2.85)改善了态度,而吸烟(β = 3.874)、子宫内膜切除术史(β = 5.506)和较长的婚姻时间(β = 0.135)使态度恶化。对于实践,较长的婚姻时间(β = 0.012)和以前的辅助生殖技术(ART)经验(β = 0.154)改善了实践,而有呼吸系统疾病史(β = -0.472)降低了实践得分。结论:本研究表明,黎巴嫩妇女怀孕困难一般有高水平的知识,积极的态度,以及良好的相关做法对不孕不育。然而,知识差距和文化因素仍然存在,突出表明需要加强生殖健康教育和对保健提供者的专门培训。
{"title":"Knowledge, Attitudes, and Practices Regarding Infertility Among Lebanese Women Experiencing Difficulty Conceiving.","authors":"Reva Mosleh, Jana Kassir, Hiba Assi, Hassan Ajami, Joseph Azoury, Roula Ajrouche, Amal Al-Hajje","doi":"10.1155/ogi/1745668","DOIUrl":"10.1155/ogi/1745668","url":null,"abstract":"<p><strong>Background: </strong>Infertility is a significant global challenge, impacting millions of individuals across the world. In Lebanon, where fertility rates are declining, understanding the knowledge, attitudes, and practices of women experiencing infertility is vital to dispelling misconceptions, improving healthcare, and offering better support for those struggling to conceive.</p><p><strong>Methods: </strong>A cross-sectional study was conducted between June and September 2024, involving 346 Lebanese women from two fertility centers in Beirut. Participants were randomly selected to complete the questionnaire through individual interviews. Descriptive and bivariate analyses were performed, and generalized linear models were used to explore the influencing factors for each of the knowledge, attitudes, and practice scores.</p><p><strong>Results: </strong>The results showed that 63.6% of participants had high knowledge, 66.2% had positive attitudes, and 82.1% exhibited good practices. The generalized linear models revealed that being a healthcare provider (<i>β</i> = 0.663), sleeping ≥ 7 h (<i>β</i> = 0.409), and having a history of anxiety (<i>β</i> = 1.258) were associated with higher knowledge scores, while advanced female age as a cause of infertility was linked to lower knowledge (<i>β</i> = -0.997). For attitudes, medical insurance (<i>β</i> = -1.312) and a family income of 1000-2000 USD (<i>β</i> = -2.85) improved attitudes, while smoking (<i>β</i> = 3.874), history of endometrial ablation (<i>β</i> = 5.506), and longer marriage duration (<i>β</i> = 0.135) worsened them. For practices, longer marriage duration (<i>β</i> = 0.012) and a previous assisted reproductive technology (ART) experience (<i>β</i> = 0.154) improved practices, while having a history of respiratory disorder (<i>β</i> = -0.472) decreased practice scores.</p><p><strong>Conclusion: </strong>This study shows that Lebanese women experiencing difficulty conceiving generally have a high level of knowledge, positive attitudes, alongside good related practices toward infertility. However, knowledge gaps and cultural factors remain, highlighting the need for enhanced reproductive health education and specialized trainings for healthcare providers.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"1745668"},"PeriodicalIF":1.3,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonconservative vs. Conservative Management of Antenatally Diagnosed Placenta Accreta Spectrum Disorders: A Literature Review of Approaches and Outcomes. 产前诊断的胎盘增生谱系障碍的非保守与保守治疗:方法和结果的文献综述。
IF 1.3 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-30 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/6344708
Tal Drozdovsky, Man Ho Kwok, Elena Greco

Placenta accreta spectrum (PAS) disorders involve abnormal placental invasion into the uterine wall and neighbouring organs, posing life-threatening risks during and after labour. Catastrophic obstetric haemorrhage remains the main morbidity factor, potentially leading to severe complications, including coagulopathy, acute respiratory distress, cardiac arrest, and, in some cases, death. The traditional, nonconservative approach, caesarean hysterectomy, is widely adopted for managing PAS, but it permanently eliminates fertility and carries a high risk of complications. In response, conservative management methods, such as the expectant approach, one-step conservative surgery and the Triple P procedure, have been developed to address the desire for fertility preservation and reduce surgical complications. Due to limited data in the field, current guidelines do not offer definitive recommendations for the most appropriate management approach in specific clinical situations. Therefore, the management of PAS disorders requires an individualised approach based on various factors, such as the extent of placental invasion, topography, ability to achieve haemostatic control, the patient's desire for future fertility, and the available medical resources and surgical expertise. The current literature review explores the efficacy and safety of both nonconservative and conservative management strategies, highlighting their impacts on maternal and neonatal outcomes, surgical morbidity and future fertility potential.

胎盘增生谱(PAS)障碍涉及胎盘异常侵入子宫壁和邻近器官,在分娩期间和分娩后构成危及生命的风险。灾难性产科出血仍然是主要的发病因素,可能导致严重并发症,包括凝血功能障碍、急性呼吸窘迫、心脏骤停,在某些情况下还会导致死亡。传统的非保守方法,剖腹产子宫切除术,被广泛用于治疗PAS,但它永久性地消除了生育能力,并有很高的并发症风险。因此,保守的治疗方法,如期待入路、一步保守手术和三重P手术,已经被开发出来,以满足保留生育能力和减少手术并发症的愿望。由于该领域的数据有限,目前的指南并没有针对具体临床情况提供最合适的管理方法的明确建议。因此,PAS疾病的管理需要基于各种因素的个性化方法,如胎盘侵犯的程度、地形、实现止血控制的能力、患者对未来生育的愿望、可用的医疗资源和外科专业知识。目前的文献综述探讨了非保守和保守治疗策略的有效性和安全性,强调了它们对孕产妇和新生儿结局、手术发病率和未来生育潜力的影响。
{"title":"Nonconservative vs. Conservative Management of Antenatally Diagnosed Placenta Accreta Spectrum Disorders: A Literature Review of Approaches and Outcomes.","authors":"Tal Drozdovsky, Man Ho Kwok, Elena Greco","doi":"10.1155/ogi/6344708","DOIUrl":"10.1155/ogi/6344708","url":null,"abstract":"<p><p>Placenta accreta spectrum (PAS) disorders involve abnormal placental invasion into the uterine wall and neighbouring organs, posing life-threatening risks during and after labour. Catastrophic obstetric haemorrhage remains the main morbidity factor, potentially leading to severe complications, including coagulopathy, acute respiratory distress, cardiac arrest, and, in some cases, death. The traditional, nonconservative approach, caesarean hysterectomy, is widely adopted for managing PAS, but it permanently eliminates fertility and carries a high risk of complications. In response, conservative management methods, such as the expectant approach, one-step conservative surgery and the Triple P procedure, have been developed to address the desire for fertility preservation and reduce surgical complications. Due to limited data in the field, current guidelines do not offer definitive recommendations for the most appropriate management approach in specific clinical situations. Therefore, the management of PAS disorders requires an individualised approach based on various factors, such as the extent of placental invasion, topography, ability to achieve haemostatic control, the patient's desire for future fertility, and the available medical resources and surgical expertise. The current literature review explores the efficacy and safety of both nonconservative and conservative management strategies, highlighting their impacts on maternal and neonatal outcomes, surgical morbidity and future fertility potential.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"6344708"},"PeriodicalIF":1.3,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767438/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of Biotin Levels in Serum and Follicular Fluid With ICSI Success: A Cross-Sectional Study From Iraq. 血清和卵泡液生物素水平与ICSI成功的关系:来自伊拉克的横断面研究。
IF 1.3 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-28 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/8841801
Zainab Abdul Ameer Jaafar, Nawal Aziz Bakir, Dina Akeel Salman

Background: Biotin (vitamin B7) has been identified as an essential cofactor within metabolism and gene expression. The purpose of this study is to evaluate the level of biotin within serum and follicular fluid aspirates among infertile women undergoing IVF cycles and to compare these levels with ovulation sensitivity and rates of pregnancy.

Methods: In this observational study with 50 patients with infertility receiving intracytoplasmic sperm injection (ICSI) treatment, women were classified according to ovarian responsiveness to anti-Mullerian hormone (AMH) levels and the number of retrieved eggs. At the time of egg retrieval, the levels of biotin in the blood and the ovarian fluid were tested. The study maintained strict reporting according to the STROBE criteria.

Results: There was no significant difference with respect to either serum levels or follicular fluids' biotin among normal responders, poor responders, and hyperresponders. In contrast, there was an inverse correlation between the values of follicular biotin and AMH (p = 0.033) and BMI (p = 0.022). The data revealed that higher numbers of total and mature oocytes had significant influences on the outcome of pregnancies (p = 0.032 and p = 0.014), respectively; however, higher values of either serum fluids' biotin or follicular fluids' biotin had no significant effect.

Conclusion: Concentrations in serum and follicular fluid of biotin do not play any role in IVF outcome. The negative correlation with AMH and BMI levels might indicate the role of biotin in the ovaries as an indicator of ovarian metabolism. The result provides valuable data in understanding the possible role of biotin in the microenvironment of the ovaries and the need to study it further.

背景:生物素(维生素B7)已被确定为代谢和基因表达的重要辅助因子。本研究的目的是评估接受体外受精周期的不孕妇女血清和卵泡液中生物素的水平,并将这些水平与排卵敏感性和怀孕率进行比较。方法:对50例接受卵胞浆内单精子注射(ICSI)治疗的不孕症患者进行观察性研究,根据卵巢对抗苗勒管激素(AMH)水平的反应性和取卵数量对患者进行分类。取卵时,检测血液和卵巢液中的生物素水平。本研究严格按照STROBE标准进行报告。结果:在正常反应者、不良反应者和超反应者中,血清水平或卵泡液生物素均无显著差异。卵泡生物素与AMH (p = 0.033)、BMI (p = 0.022)呈负相关。数据显示,总卵母细胞和成熟卵母细胞数量的增加对妊娠结局有显著影响(p = 0.032和p = 0.014);然而,血清生物素或卵泡液生物素的较高值均无显著影响。结论:血清和卵泡液生物素浓度对体外受精结果无影响。与AMH和BMI水平呈负相关,可能提示生物素在卵巢中作为卵巢代谢指标的作用。该结果为了解生物素在卵巢微环境中的可能作用以及进一步研究的必要性提供了有价值的数据。
{"title":"Associations of Biotin Levels in Serum and Follicular Fluid With ICSI Success: A Cross-Sectional Study From Iraq.","authors":"Zainab Abdul Ameer Jaafar, Nawal Aziz Bakir, Dina Akeel Salman","doi":"10.1155/ogi/8841801","DOIUrl":"10.1155/ogi/8841801","url":null,"abstract":"<p><strong>Background: </strong>Biotin (vitamin B7) has been identified as an essential cofactor within metabolism and gene expression. The purpose of this study is to evaluate the level of biotin within serum and follicular fluid aspirates among infertile women undergoing IVF cycles and to compare these levels with ovulation sensitivity and rates of pregnancy.</p><p><strong>Methods: </strong>In this observational study with 50 patients with infertility receiving intracytoplasmic sperm injection (ICSI) treatment, women were classified according to ovarian responsiveness to anti-Mullerian hormone (AMH) levels and the number of retrieved eggs. At the time of egg retrieval, the levels of biotin in the blood and the ovarian fluid were tested. The study maintained strict reporting according to the STROBE criteria.</p><p><strong>Results: </strong>There was no significant difference with respect to either serum levels or follicular fluids' biotin among normal responders, poor responders, and hyperresponders. In contrast, there was an inverse correlation between the values of follicular biotin and AMH (<i>p</i> = 0.033) and BMI (<i>p</i> = 0.022). The data revealed that higher numbers of total and mature oocytes had significant influences on the outcome of pregnancies (<i>p</i> = 0.032 and <i>p</i> = 0.014), respectively; however, higher values of either serum fluids' biotin or follicular fluids' biotin had no significant effect.</p><p><strong>Conclusion: </strong>Concentrations in serum and follicular fluid of biotin do not play any role in IVF outcome. The negative correlation with AMH and BMI levels might indicate the role of biotin in the ovaries as an indicator of ovarian metabolism. The result provides valuable data in understanding the possible role of biotin in the microenvironment of the ovaries and the need to study it further.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"8841801"},"PeriodicalIF":1.3,"publicationDate":"2025-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767373/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Universal Utilization of Optimally Timed First Obstetric Ultrasound Among Pregnant Women in a Low-Middle Income Country: A Multicenter Prospective Study. 中低收入国家孕妇普遍使用最佳时间首次产科超声:一项多中心前瞻性研究。
IF 1.3 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-23 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/5797924
Sisay Kirba, Abdulfetah Abdulkedir Abdosh, Ekram Muhammedasrar, Abraham Fessehaye Sium

Background: Currently, the World Health Organization guidelines recommend universal utilization of optimally timed first obstetric ultrasound (defined as ultrasound before 24 weeks) in low-middle income countries. However, there is inadequate evidence on this topic from these countries. Our study aimed to determine the rate of utilization of optimally timed first obstetric ultrasound among pregnant women who gave birth at three public hospitals in Ethiopia.

Methods: This was a multicenter prospective cross-sectional study conducted on the utilization of optimally timed first obstetric ultrasound among pregnant women who delivered at public hospitals in Ethiopia in 2020. Data were collected prospectively using a structured questionnaire. Data were analyzed using SPSS Version 20. Simple descriptive statistics, chi-squared test, and multiple regression analysis were performed as appropriate. p value less than 0.05 and adjusted odds ratio (AOR) with 95% CI were used to present result significance.

Results: A total of 385 participants were included in this study. Approximately 67.5% of pregnant mothers had optimally timed 1st ultrasound. Compared to those having antenatal care (ANC) at health centers, those who started their ANC at private clinic were 1.7 times (95 CI: 1.8-7.9) more likely to have optimally timed ANC. Those who had their 1st ANC at private hospital were 3.2 times (95 CI: 1.8-7.9) more likely to have optimally timed 1st prenatal care. Those who had their first ANC at private health institutions and government hospitals were much more likely to have optimally timed 1st prenatal ultrasound with the following AOR for government hospital and private MCH centers: AOR = 7.4 (95 CI: 2.7-23) and AOR = 4.9 (95 CI: 2.8-14.1), respectively. Those who had previous major obstetric problem were 5.2 times (95 CI: 2.7-9.9) more likely to have optimally timed ultrasound than those without major previous obstetric problem.

Conclusion: We found that one-third of pregnant women did not utilize optimally timed first obstetric ultrasound, despite obstetric ultrasound services being accessible at public health institutions. Place of first ANC contact and presence of prior major obstetric complication were associated with utilization of optimally dated first obstetric ultrasound.

背景:目前,世界卫生组织指南建议在中低收入国家普遍使用最佳时间首次产科超声(定义为24周前的超声)。然而,这些国家关于这一主题的证据不足。我们的研究旨在确定在埃塞俄比亚三家公立医院分娩的孕妇中最佳时间首次产科超声的使用率。方法:这是一项多中心前瞻性横断面研究,对2020年在埃塞俄比亚公立医院分娩的孕妇中最佳时间首次产科超声的使用情况进行了研究。使用结构化问卷前瞻性地收集数据。数据分析使用SPSS Version 20。适当时进行简单描述性统计、卡方检验和多元回归分析。p值< 0.05,采用校正优势比(AOR)和95% CI表示结果显著性。结果:本研究共纳入385名受试者。约67.5%的孕妇在最佳时间进行了第一次超声检查。与在卫生中心进行产前护理(ANC)的人相比,在私人诊所开始产前护理的人获得最佳时间ANC的可能性是后者的1.7倍(95 CI: 1.8-7.9)。那些在私立医院进行第一次产前分娩的人有3.2倍(95 CI: 1.8-7.9)更有可能在最佳时间进行第一次产前护理。在私立医疗机构和公立医院进行首次ANC的患者更有可能在以下AOR(公立医院和私立妇幼保健中心)进行第一次产前超声的最佳时间:AOR = 7.4 (95 CI: 2.7-23)和AOR = 4.9 (95 CI: 2.8-14.1)。既往有重大产科问题的患者比既往无重大产科问题的患者获得最佳超声时间的可能性高5.2倍(95 CI: 2.7-9.9)。结论:我们发现,尽管公共卫生机构提供产科超声服务,但三分之一的孕妇没有利用最佳时间的首次产科超声。首次接触ANC的地点和既往主要产科并发症的存在与使用最佳日期的首次产科超声有关。
{"title":"Universal Utilization of Optimally Timed First Obstetric Ultrasound Among Pregnant Women in a Low-Middle Income Country: A Multicenter Prospective Study.","authors":"Sisay Kirba, Abdulfetah Abdulkedir Abdosh, Ekram Muhammedasrar, Abraham Fessehaye Sium","doi":"10.1155/ogi/5797924","DOIUrl":"10.1155/ogi/5797924","url":null,"abstract":"<p><strong>Background: </strong>Currently, the World Health Organization guidelines recommend universal utilization of optimally timed first obstetric ultrasound (defined as ultrasound before 24 weeks) in low-middle income countries. However, there is inadequate evidence on this topic from these countries. Our study aimed to determine the rate of utilization of optimally timed first obstetric ultrasound among pregnant women who gave birth at three public hospitals in Ethiopia.</p><p><strong>Methods: </strong>This was a multicenter prospective cross-sectional study conducted on the utilization of optimally timed first obstetric ultrasound among pregnant women who delivered at public hospitals in Ethiopia in 2020. Data were collected prospectively using a structured questionnaire. Data were analyzed using SPSS Version 20. Simple descriptive statistics, chi-squared test, and multiple regression analysis were performed as appropriate. <i>p</i> value less than 0.05 and adjusted odds ratio (AOR) with 95% CI were used to present result significance.</p><p><strong>Results: </strong>A total of 385 participants were included in this study. Approximately 67.5% of pregnant mothers had optimally timed 1<sup>st</sup> ultrasound. Compared to those having antenatal care (ANC) at health centers, those who started their ANC at private clinic were 1.7 times (95 CI: 1.8-7.9) more likely to have optimally timed ANC. Those who had their 1<sup>st</sup> ANC at private hospital were 3.2 times (95 CI: 1.8-7.9) more likely to have optimally timed 1<sup>st</sup> prenatal care. Those who had their first ANC at private health institutions and government hospitals were much more likely to have optimally timed 1<sup>st</sup> prenatal ultrasound with the following AOR for government hospital and private MCH centers: AOR = 7.4 (95 CI: 2.7-23) and AOR = 4.9 (95 CI: 2.8-14.1), respectively. Those who had previous major obstetric problem were 5.2 times (95 CI: 2.7-9.9) more likely to have optimally timed ultrasound than those without major previous obstetric problem.</p><p><strong>Conclusion: </strong>We found that one-third of pregnant women did not utilize optimally timed first obstetric ultrasound, despite obstetric ultrasound services being accessible at public health institutions. Place of first ANC contact and presence of prior major obstetric complication were associated with utilization of optimally dated first obstetric ultrasound.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"5797924"},"PeriodicalIF":1.3,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767423/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Associated With Low Utilization of Cervical Cancer Screening Services in Gazipur, Bangladesh. 孟加拉国加齐浦尔宫颈癌筛查服务使用率低的相关因素
IF 1.3 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-22 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/4476955
Sadia Fatema Kabir, Muhammad Ashik-Ur-Rahman, Abdur Rahman, Md Afzal Hossen, Rowfun Rahman, Farhana Huq, Mohibbul Haque, Junnatul Fardous Marfi, Md Abdullah Saeed Khan, Mohammad Delwer Hossain Hawlader

Background: Despite its availability, cervical cancer screening services continue to remain underutilized in many regions. This study aimed to assess the prevalence and determinants of cervical cancer screening uptake among women in the north-central area of Bangladesh.

Methods: In this cross-sectional study, between May and October 2022, women aged 30-60 years attending a tertiary care hospital in Gazipur district were approached for inclusion. Face-to-face interviews were conducted using a semistructured questionnaire. A total of 252 women were consecutively recruited within the study period. The self-reported screening practice was recorded and verified by matching with identification numbers provided for screening by the hospital, and reasons for nonutilization were also collected.

Results: Only 12 women (4.76%) had ever been screened for cervical cancer. Lower knowledge scores (OR: 0.26 and 95% CI: 0.08-0.95) were associated with higher odds of nonutilization of cervical cancer screening services on multivariable analysis. Despite high awareness of symptoms and risk factors, only 15.08% knew that screening prevents cancer. The main reasons for not getting screened were fear of pain (98.33%) and feeling shy (52.50%).

Conclusion: Awareness-increasing programs are recommended to improve the utilization of cervical cancer screening among women.

背景:尽管有宫颈癌筛查服务,但在许多地区仍未充分利用。本研究旨在评估孟加拉国中北部地区妇女宫颈癌筛查的患病率和决定因素。方法:在这项横断面研究中,在2022年5月至10月期间,在Gazipur地区一家三级保健医院就诊的30-60岁妇女被纳入研究。面对面访谈采用半结构化问卷进行。在研究期间,共有252名女性被连续招募。记录自我报告的筛查实践,并与医院提供的筛查识别号码相匹配进行验证,并收集不使用的原因。结果:仅有12名妇女(4.76%)接受过宫颈癌筛查。在多变量分析中,较低的知识得分(OR: 0.26, 95% CI: 0.08-0.95)与较高的不使用宫颈癌筛查服务的几率相关。尽管对症状和危险因素的认识很高,但只有15.08%的人知道筛查可以预防癌症。不接受筛查的主要原因是害怕疼痛(98.33%)和害羞(52.50%)。结论:建议开展提高认识的项目,以提高妇女宫颈癌筛查的利用率。
{"title":"Factors Associated With Low Utilization of Cervical Cancer Screening Services in Gazipur, Bangladesh.","authors":"Sadia Fatema Kabir, Muhammad Ashik-Ur-Rahman, Abdur Rahman, Md Afzal Hossen, Rowfun Rahman, Farhana Huq, Mohibbul Haque, Junnatul Fardous Marfi, Md Abdullah Saeed Khan, Mohammad Delwer Hossain Hawlader","doi":"10.1155/ogi/4476955","DOIUrl":"10.1155/ogi/4476955","url":null,"abstract":"<p><strong>Background: </strong>Despite its availability, cervical cancer screening services continue to remain underutilized in many regions. This study aimed to assess the prevalence and determinants of cervical cancer screening uptake among women in the north-central area of Bangladesh.</p><p><strong>Methods: </strong>In this cross-sectional study, between May and October 2022, women aged 30-60 years attending a tertiary care hospital in Gazipur district were approached for inclusion. Face-to-face interviews were conducted using a semistructured questionnaire. A total of 252 women were consecutively recruited within the study period. The self-reported screening practice was recorded and verified by matching with identification numbers provided for screening by the hospital, and reasons for nonutilization were also collected.</p><p><strong>Results: </strong>Only 12 women (4.76%) had ever been screened for cervical cancer. Lower knowledge scores (OR: 0.26 and 95% CI: 0.08-0.95) were associated with higher odds of nonutilization of cervical cancer screening services on multivariable analysis. Despite high awareness of symptoms and risk factors, only 15.08% knew that screening prevents cancer. The main reasons for not getting screened were fear of pain (98.33%) and feeling shy (52.50%).</p><p><strong>Conclusion: </strong>Awareness-increasing programs are recommended to improve the utilization of cervical cancer screening among women.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"4476955"},"PeriodicalIF":1.3,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Cohort Study of Pregnancy Maternal Outcomes of Women With COVID-19 in King Salman Armed Forces Hospital, Tabuk, Kingdom of Saudi Arabia. 沙特阿拉伯王国塔布克萨勒曼国王武装部队医院COVID-19妇女妊娠和孕产妇结局的回顾性队列研究
IF 1.3 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-22 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/3287655
Abdulrahman Wasel Koja, Rofayda Mansour Ahmed Mohamad, Mubarak Saleh Almarjan, Mayar Hamed Albakri

Aim: This study aimed to evaluate the adverse maternal and neonatal outcomes among pregnant women with COVID-19 at King Salman Armed Forces Hospital in Tabuk and examine the relationship between the severity of COVID-19 infection and these outcomes.

Methods: This retrospective cohort study enrolled COVID-19-positive pregnant women. Demographic and obstetric information, clinical characteristics (including symptoms and preexisting comorbid conditions), and maternal and neonatal outcomes were collected from medical records, reviewed, and analyzed.

Results: The study included 138 COVID-19-positive women, with the majority of cases diagnosed in the third trimester (85.5%). Assessment of the severity of COVID-19 infection showed that a large proportion were asymptomatic (39.1%) or had mild disease (39.9%), while 14.5% had moderate disease and 6.5% experienced severe illness. Adverse maternal and neonatal outcomes included preeclampsia (5.1%), gestational diabetes (4.3%), placental abruption, premature rupture of membranes (2.9% each), maternal intensive care unit (ICU) admission (1.4%), preterm births (12.3%), low birth weight (15.2%), and neonatal ICU admission (10.1%). Additionally, the incidences of preeclampsia and maternal ICU admission were significantly higher in women with severe COVID-19 compared to those with milder or asymptomatic cases (p = 0.004 each). Neonatal ICU admission showed the highest incidence (33.3%) among severe cases (p = 0.031). Asthma was significantly linked to a higher risk of neonatal ICU admission (23.1% vs. 7.1%). Diabetes mellitus was associated with an increased rate of maternal ICU admission (13.3% vs. 0%). Hypertension showed significant associations with elevated rates of preeclampsia (35.7% vs. 1.6%), maternal ICU admission (14.3% vs. 0%), and neonatal ICU admission (35.7% vs. 7.3%).

Conclusion: COVID-19 infection during pregnancy was associated with several adverse maternal and neonatal outcomes, including preeclampsia, gestational diabetes, preterm birth, low birth weight, and increased ICU admissions. Severe maternal disease and existing comorbidities further elevated the risks of complications for both mother and newborn.

目的:本研究旨在评估Tabuk萨勒曼国王武装部队医院感染COVID-19的孕妇的不良孕产妇和新生儿结局,并研究COVID-19感染严重程度与这些结局之间的关系。方法:采用回顾性队列研究,纳入新冠病毒阳性孕妇。从医疗记录中收集人口统计和产科信息、临床特征(包括症状和先前存在的合并症)以及孕产妇和新生儿结局,进行审查和分析。结果:本研究纳入138例新冠病毒阳性妇女,大多数病例在妊娠晚期确诊(85.5%)。COVID-19感染严重程度评估显示,无症状(39.1%)或轻度疾病(39.9%)占很大比例,中度疾病占14.5%,重度疾病占6.5%。孕产妇和新生儿不良结局包括先兆子痫(5.1%)、妊娠糖尿病(4.3%)、胎盘早剥、胎膜早破(各2.9%)、孕产妇入住重症监护病房(ICU)(1.4%)、早产(12.3%)、低出生体重(15.2%)和新生儿入住ICU(10.1%)。此外,重症COVID-19患者先兆子痫和产妇ICU住院的发生率明显高于轻症或无症状患者(p = 0.004)。新生儿重症住院发生率最高,为33.3% (p = 0.031)。哮喘与新生儿进入ICU的高风险显著相关(23.1%对7.1%)。糖尿病与产妇ICU入院率增加相关(13.3%对0%)。高血压与先兆子痫发生率升高(35.7%比1.6%)、产妇ICU入院率(14.3%比0%)和新生儿ICU入院率(35.7%比7.3%)显著相关。结论:妊娠期COVID-19感染与多种孕产妇和新生儿不良结局相关,包括先兆子痫、妊娠期糖尿病、早产、低出生体重和ICU入院率增加。严重的孕产妇疾病和现有的合并症进一步增加了母亲和新生儿发生并发症的风险。
{"title":"Retrospective Cohort Study of Pregnancy Maternal Outcomes of Women With COVID-19 in King Salman Armed Forces Hospital, Tabuk, Kingdom of Saudi Arabia.","authors":"Abdulrahman Wasel Koja, Rofayda Mansour Ahmed Mohamad, Mubarak Saleh Almarjan, Mayar Hamed Albakri","doi":"10.1155/ogi/3287655","DOIUrl":"10.1155/ogi/3287655","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to evaluate the adverse maternal and neonatal outcomes among pregnant women with COVID-19 at King Salman Armed Forces Hospital in Tabuk and examine the relationship between the severity of COVID-19 infection and these outcomes.</p><p><strong>Methods: </strong>This retrospective cohort study enrolled COVID-19-positive pregnant women. Demographic and obstetric information, clinical characteristics (including symptoms and preexisting comorbid conditions), and maternal and neonatal outcomes were collected from medical records, reviewed, and analyzed.</p><p><strong>Results: </strong>The study included 138 COVID-19-positive women, with the majority of cases diagnosed in the third trimester (85.5%). Assessment of the severity of COVID-19 infection showed that a large proportion were asymptomatic (39.1%) or had mild disease (39.9%), while 14.5% had moderate disease and 6.5% experienced severe illness. Adverse maternal and neonatal outcomes included preeclampsia (5.1%), gestational diabetes (4.3%), placental abruption, premature rupture of membranes (2.9% each), maternal intensive care unit (ICU) admission (1.4%), preterm births (12.3%), low birth weight (15.2%), and neonatal ICU admission (10.1%). Additionally, the incidences of preeclampsia and maternal ICU admission were significantly higher in women with severe COVID-19 compared to those with milder or asymptomatic cases (<i>p</i> = 0.004 each). Neonatal ICU admission showed the highest incidence (33.3%) among severe cases (<i>p</i> = 0.031). Asthma was significantly linked to a higher risk of neonatal ICU admission (23.1% vs. 7.1%). Diabetes mellitus was associated with an increased rate of maternal ICU admission (13.3% vs. 0%). Hypertension showed significant associations with elevated rates of preeclampsia (35.7% vs. 1.6%), maternal ICU admission (14.3% vs. 0%), and neonatal ICU admission (35.7% vs. 7.3%).</p><p><strong>Conclusion: </strong>COVID-19 infection during pregnancy was associated with several adverse maternal and neonatal outcomes, including preeclampsia, gestational diabetes, preterm birth, low birth weight, and increased ICU admissions. Severe maternal disease and existing comorbidities further elevated the risks of complications for both mother and newborn.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"3287655"},"PeriodicalIF":1.3,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767420/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When to Choose In Vitro Fertilization (IVF) When Postponing Conceiving: The Age-Related Risk of IVF Failure at an Advanced Age. 当推迟怀孕时何时选择体外受精(IVF):高龄时体外受精失败的年龄相关风险。
IF 1.3 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/2407539
Zhiyan Chen, Duoduo Zhang, Zhengyi Sun, Qi Yu, Chenyang Zhao, ChangZhong Li

Background: To validate previous age subgrouping methods and provide an optimal age reference for women planning to delay in vitro fertilization (IVF).

Methods: From July 2014 to March 2018, 3012 patients that received IVF/intracytoplasmic sperm injection (ICSI) were continuously recruited in this retrospective, single-center study. We analyzed the relationships of baseline characteristics and IVF outcomes. A smooth fitting curve depicting the association of age and live birth was plotted using the generalized additive model (GAM) method. We also evaluated the association of age and live birth among different age groups (> 20, ≤ 35; > 35, ≤ 37; > 37, ≤ 40; and > 40).

Results: Age, duration of infertility, and baseline follicle-stimulating hormone (FSH) were significantly related to the live birth rate. The adjusted Odd Ratio (OR) value of age was 0.95 (P < 0.001), indicating the higher occurrence of no live birth with age increasing. The fitting curve showed that the live birth rate decreased with age. And 35.5 (34.5-36.5) was identified as the inflection point of the curve. The slopes before 35.5 and after 35.5 were significantly different (0.9 [0.9, 1.0], P < 0.001). When ≤ 35, live birth rate did not vary with age. For the ages of 35-37 and 37-40, the occurrence of negative outcome increased with age (aOR: 0.73 [0.53, 0.99], 0.80 [0.65, 1.00]; P = 0.0441, 0.0465, respectively).

Conclusion: The age of 35 can be referred to as the safe time point when the IVF success rate does not decline with age. And the risk of IVF failure increases rapidly in the period of 35-37 and 37-40.

背景:验证以往的年龄亚分组方法,为计划推迟体外受精(IVF)的女性提供最佳年龄参考。方法:2014年7月至2018年3月,连续招募3012例接受体外受精/卵胞浆内单精子注射(ICSI)的患者进行回顾性单中心研究。我们分析了基线特征与IVF结果的关系。使用广义加性模型(GAM)方法绘制了描绘年龄与活产关联的平滑拟合曲线。我们还评估了不同年龄组(>0岁,≤35岁;> 35岁,≤37岁;> 37岁,≤40岁;> 40岁)年龄与活产的关系。结果:年龄、不孕持续时间和基线促卵泡激素(FSH)与活产率显著相关。年龄调整后的Odd Ratio (OR)值为0.95 (P < 0.001),提示随着年龄的增加,无活产发生率增高。拟合曲线显示,活产率随年龄的增长而下降。35.5(34.5-36.5)为曲线拐点。35.5之前和35.5之后的斜率有显著差异(0.9 [0.9,1.0],P < 0.001)。≤35岁时,活产率不随年龄变化。35 ~ 37岁、37 ~ 40岁不良结局发生率随年龄增长而增加(aOR分别为0.73[0.53,0.99]、0.80 [0.65,1.00];P分别为0.0441、0.0465)。结论:35岁可作为IVF成功率不随年龄增长而下降的安全时间点。35-37岁和37-40岁是IVF失败的高危年龄段。
{"title":"When to Choose In Vitro Fertilization (IVF) When Postponing Conceiving: The Age-Related Risk of IVF Failure at an Advanced Age.","authors":"Zhiyan Chen, Duoduo Zhang, Zhengyi Sun, Qi Yu, Chenyang Zhao, ChangZhong Li","doi":"10.1155/ogi/2407539","DOIUrl":"10.1155/ogi/2407539","url":null,"abstract":"<p><strong>Background: </strong>To validate previous age subgrouping methods and provide an optimal age reference for women planning to delay in vitro fertilization (IVF).</p><p><strong>Methods: </strong>From July 2014 to March 2018, 3012 patients that received IVF/intracytoplasmic sperm injection (ICSI) were continuously recruited in this retrospective, single-center study. We analyzed the relationships of baseline characteristics and IVF outcomes. A smooth fitting curve depicting the association of age and live birth was plotted using the generalized additive model (GAM) method. We also evaluated the association of age and live birth among different age groups (> 20, ≤ 35; > 35, ≤ 37; > 37, ≤ 40; and > 40).</p><p><strong>Results: </strong>Age, duration of infertility, and baseline follicle-stimulating hormone (FSH) were significantly related to the live birth rate. The adjusted Odd Ratio (OR) value of age was 0.95 (<i>P</i> < 0.001), indicating the higher occurrence of no live birth with age increasing. The fitting curve showed that the live birth rate decreased with age. And 35.5 (34.5-36.5) was identified as the inflection point of the curve. The slopes before 35.5 and after 35.5 were significantly different (0.9 [0.9, 1.0], <i>P</i> < 0.001). When ≤ 35, live birth rate did not vary with age. For the ages of 35-37 and 37-40, the occurrence of negative outcome increased with age (aOR: 0.73 [0.53, 0.99], 0.80 [0.65, 1.00]; <i>P</i> = 0.0441, 0.0465, respectively).</p><p><strong>Conclusion: </strong>The age of 35 can be referred to as the safe time point when the IVF success rate does not decline with age. And the risk of IVF failure increases rapidly in the period of 35-37 and 37-40.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"2407539"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Motor Vehicle Driving During Pregnancy Does Not Influence Uterine Contractions. 怀孕期间驾驶机动车辆不会影响子宫收缩。
IF 1.3 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-08 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/3096143
Riko Araki, Masahito Hitosugi, Kentaro Takahashi

Background: No studies have effectively clarified the relationship between uterine contractions and the act of acceleration or driving behaviors in pregnant women.

Aims: To confirm the effect of driving a motor vehicle on physiological changes in pregnant women, we examined uterine contractions while driving.

Materials and methods: Seventeen pregnant women with a gestational age of 30-35 weeks were enrolled in this study. Uterine contractions were monitored remotely using a mobile delivery monitoring device. Triaxial acceleration of the vehicle, vehicle velocity, and vehicle kinematics were monitored using a driving recorder.

Results: The average number of uterine contractions per 30 min in all participants was 1.0 (range, 0.26-2.0). When comparing the median vehicle velocity during a uterine contraction with that when there were no contractions, no significant difference was found (23 km/hour vs. 31 km/hour, p = 0.36). The prevalence of low velocity (20 km/hour or less) was significantly higher, and that of higher velocity (50 km/hour or more) was lower during a uterine contraction than with no contractions (p = 0.023 and 0.012, respectively). When comparing resultant vehicle acceleration, no significant differences were found between women with uterine contractions and those with no contractions. The distributions were similar before and immediately before a uterine contraction and with no contractions.

Conclusions: Driving a motor vehicle should be considered a normal activity of daily life in pregnant women and seems unlikely to predispose to preterm birth.

背景:目前尚无研究有效阐明孕妇子宫收缩与加速行为或驾驶行为之间的关系。目的:为了确认驾驶机动车对孕妇生理变化的影响,我们检测了驾车时子宫收缩。材料与方法:17例孕周30-35周的孕妇入选本研究。使用移动分娩监测装置远程监测子宫收缩。使用驾驶记录仪监测车辆的三轴加速度、车辆速度和车辆运动学。结果:所有参与者平均每30分钟子宫收缩次数为1.0次(范围0.26-2.0)。子宫收缩时与无宫缩时的车速中位数比较,差异无统计学意义(23 km/h vs 31 km/h, p = 0.36)。子宫收缩时低速(20km /h以下)的发生率显著高于无宫缩时,高速(50km /h以上)的发生率显著低于无宫缩时(p = 0.023和0.012)。当比较由此产生的车辆加速度时,在子宫收缩的妇女和没有子宫收缩的妇女之间没有发现显著差异。子宫收缩前、紧接前和无宫缩时的分布相似。结论:驾驶机动车应被视为孕妇日常生活的正常活动,似乎不太可能导致早产。
{"title":"Motor Vehicle Driving During Pregnancy Does Not Influence Uterine Contractions.","authors":"Riko Araki, Masahito Hitosugi, Kentaro Takahashi","doi":"10.1155/ogi/3096143","DOIUrl":"10.1155/ogi/3096143","url":null,"abstract":"<p><strong>Background: </strong>No studies have effectively clarified the relationship between uterine contractions and the act of acceleration or driving behaviors in pregnant women.</p><p><strong>Aims: </strong>To confirm the effect of driving a motor vehicle on physiological changes in pregnant women, we examined uterine contractions while driving.</p><p><strong>Materials and methods: </strong>Seventeen pregnant women with a gestational age of 30-35 weeks were enrolled in this study. Uterine contractions were monitored remotely using a mobile delivery monitoring device. Triaxial acceleration of the vehicle, vehicle velocity, and vehicle kinematics were monitored using a driving recorder.</p><p><strong>Results: </strong>The average number of uterine contractions per 30 min in all participants was 1.0 (range, 0.26-2.0). When comparing the median vehicle velocity during a uterine contraction with that when there were no contractions, no significant difference was found (23 km/hour vs. 31 km/hour, <i>p</i> = 0.36). The prevalence of low velocity (20 km/hour or less) was significantly higher, and that of higher velocity (50 km/hour or more) was lower during a uterine contraction than with no contractions (<i>p</i> = 0.023 and 0.012, respectively). When comparing resultant vehicle acceleration, no significant differences were found between women with uterine contractions and those with no contractions. The distributions were similar before and immediately before a uterine contraction and with no contractions.</p><p><strong>Conclusions: </strong>Driving a motor vehicle should be considered a normal activity of daily life in pregnant women and seems unlikely to predispose to preterm birth.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"3096143"},"PeriodicalIF":1.3,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767404/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Pregnancy Rate and Live Birth Rate of Intracytoplasmic Sperm Injection Cycles Using Fresh Versus Frozen-Thawed Testicular Sperm. 新鲜和冷冻解冻睾丸精子注射周期妊娠率和活产率的比较。
IF 1.3 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-10 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/5544073
Zeyad Mohammed Abualiat, Joud Sami Makki, Shahad Mubarak Aljebeli, Rawan Othman Bamousa, Orjowan Zuhair Alamri, Alwaten Fahad Alabdullah, Haya Al Fozan
<p><strong>Objectives: </strong>The primary objective of the study is to compare the rate of pregnancy and live birth rate in infertile couples with nonobstructive azoospermia (NOA) treated with either fresh or frozen sperms in intracytoplasmic sperm injection (ICSI) cycles. It is already known that the use of frozen sperm in ICSI cycles is considered favorable and is reported to have no significant difference in outcomes when compared to fresh sperm. However, there is still an ongoing debate about the superiority of fresh or frozen-thawed spermatozoa in men with NOA, particularly in the context of Saudi Arabia where this subject has not been previously investigated.</p><p><strong>Design: </strong>This retrospective cohort study was conducted at the in vitro fertilization (IVF) unit at KAMC-R, Ministry of National Guard Hospital Affairs (MNGHA) in Riyadh, Saudi Arabia. It includes couples who underwent ICSI cycles throughout four years (2019-2022), provided that they had no female infertility causes. A checklist was prepared to collect data from patients' medical records.</p><p><strong>Participants setting and methods: </strong>This retrospective cohort study analyzed data from 230 infertile couples who underwent ICSI cycles between 2019 and 2022. We compared pregnancy, live birth, and overall success rates in cycles using fresh versus frozen-thawed testicular sperm, controlling for factors like age, infertility type, and hormone levels. Statistical analysis included chi-square tests, Fisher's exact tests, Student's <i>t</i> tests, and Mann-Whitney tests to compare outcomes between groups.</p><p><strong>Results: </strong>A total of 231 women were included. Their mean ± standard deviation (SD) age was 31.5 ± 5.4. Almost two-thirds (67.5%) had primary infertility. Regarding the type of sperms used in intracytoplasmic sperm injection, fresh sperms represented 57.1%, while the remaining 42.9% were frozen sperms. Rates of pregnancy, live births, ectopic pregnancy, and abortion were 32.5%, 23.5%, 3.5%, and 5.7%, respectively. Overall, the success rate of ICSI was 29.8%. The pregnancy rate was significantly higher using fresh spermatozoa in ICSI than frozen spermatozoa (37.9% vs. 25.3%), <i>p</i>=0.043. Similarly, live births and overall successful outcome rates of using fresh spermatozoa in ICSI were significantly higher than those of frozen spermatozoa (28.8% and 34.8% vs. 16% and 22.6%), <i>p</i>=0.025 and 0.048, respectively.</p><p><strong>Limitations: </strong>The study demonstrated an association between fresh sperm use and higher success rates, but it did not prove causality.</p><p><strong>Conclusion: </strong>When both fresh and frozen sperm were used, the rates of pregnancy, live birth, and overall success in ICSI were higher in fresh sperm. Additionally, younger males and females showed a greater likelihood of successful ICSI outcomes. There is a potential benefit of using fresh sperm in ICSI for this specific patient group but highlights the
目的:本研究的主要目的是比较在卵胞浆内单精子注射(ICSI)周期中使用新鲜或冷冻精子治疗非阻塞性无精子症(NOA)的不孕夫妇的妊娠率和活产率。众所周知,在ICSI周期中使用冷冻精子被认为是有利的,据报道,与新鲜精子相比,冷冻精子的结果没有显著差异。然而,关于新鲜或冷冻解冻精子对NOA男性的优势仍存在争议,特别是在沙特阿拉伯的背景下,这个问题以前没有进行过调查。设计:本回顾性队列研究在沙特阿拉伯利雅得国民警卫队医院事务部(MNGHA) KAMC-R的体外受精(IVF)部门进行。它包括在四年内(2019-2022年)进行ICSI周期的夫妇,前提是他们没有女性不育的原因。准备了一份清单,从病人的医疗记录中收集数据。参与者设置和方法:这项回顾性队列研究分析了2019年至2022年间接受ICSI周期的230对不孕夫妇的数据。在控制年龄、不育类型和激素水平等因素的情况下,我们比较了使用新鲜睾丸精子和冷冻解冻睾丸精子的怀孕、活产和总成功率。统计分析包括卡方检验、Fisher精确检验、学生t检验和Mann-Whitney检验来比较组间结果。结果:共纳入231名女性。平均±标准差(SD)年龄为31.5±5.4岁。几乎三分之二(67.5%)为原发性不孕症。就卵胞浆内单精子注射使用的精子类型而言,新鲜精子占57.1%,其余42.9%为冷冻精子。妊娠率为32.5%,活产率为23.5%,异位妊娠率为3.5%,流产率为5.7%。总体而言,ICSI成功率为29.8%。使用新鲜精子进行ICSI的受孕率明显高于冷冻精子(37.9% vs. 25.3%), p=0.043。同样,在ICSI中使用新鲜精子的活产率和总成功率显著高于冷冻精子(28.8%和34.8% vs. 16%和22.6%),p分别=0.025和0.048。局限性:该研究证明了新鲜精子的使用与更高的成功率之间的联系,但它没有证明因果关系。结论:冷冻和新鲜精子同时使用时,新鲜精子的受孕率、活产率和ICSI的总体成功率更高。此外,年轻的男性和女性更有可能成功进行ICSI。对于这一特定的患者群体,在ICSI中使用新鲜精子有潜在的好处,但强调需要进一步的研究来巩固这些发现,并探索观察到的差异背后的原因。这项研究增加了NOA男性ICSI的知识体系,并强调需要进一步研究以完善临床实践并改善不育夫妇的结果。
{"title":"Comparison of Pregnancy Rate and Live Birth Rate of Intracytoplasmic Sperm Injection Cycles Using Fresh Versus Frozen-Thawed Testicular Sperm.","authors":"Zeyad Mohammed Abualiat, Joud Sami Makki, Shahad Mubarak Aljebeli, Rawan Othman Bamousa, Orjowan Zuhair Alamri, Alwaten Fahad Alabdullah, Haya Al Fozan","doi":"10.1155/ogi/5544073","DOIUrl":"10.1155/ogi/5544073","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;The primary objective of the study is to compare the rate of pregnancy and live birth rate in infertile couples with nonobstructive azoospermia (NOA) treated with either fresh or frozen sperms in intracytoplasmic sperm injection (ICSI) cycles. It is already known that the use of frozen sperm in ICSI cycles is considered favorable and is reported to have no significant difference in outcomes when compared to fresh sperm. However, there is still an ongoing debate about the superiority of fresh or frozen-thawed spermatozoa in men with NOA, particularly in the context of Saudi Arabia where this subject has not been previously investigated.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;This retrospective cohort study was conducted at the in vitro fertilization (IVF) unit at KAMC-R, Ministry of National Guard Hospital Affairs (MNGHA) in Riyadh, Saudi Arabia. It includes couples who underwent ICSI cycles throughout four years (2019-2022), provided that they had no female infertility causes. A checklist was prepared to collect data from patients' medical records.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants setting and methods: &lt;/strong&gt;This retrospective cohort study analyzed data from 230 infertile couples who underwent ICSI cycles between 2019 and 2022. We compared pregnancy, live birth, and overall success rates in cycles using fresh versus frozen-thawed testicular sperm, controlling for factors like age, infertility type, and hormone levels. Statistical analysis included chi-square tests, Fisher's exact tests, Student's &lt;i&gt;t&lt;/i&gt; tests, and Mann-Whitney tests to compare outcomes between groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 231 women were included. Their mean ± standard deviation (SD) age was 31.5 ± 5.4. Almost two-thirds (67.5%) had primary infertility. Regarding the type of sperms used in intracytoplasmic sperm injection, fresh sperms represented 57.1%, while the remaining 42.9% were frozen sperms. Rates of pregnancy, live births, ectopic pregnancy, and abortion were 32.5%, 23.5%, 3.5%, and 5.7%, respectively. Overall, the success rate of ICSI was 29.8%. The pregnancy rate was significantly higher using fresh spermatozoa in ICSI than frozen spermatozoa (37.9% vs. 25.3%), &lt;i&gt;p&lt;/i&gt;=0.043. Similarly, live births and overall successful outcome rates of using fresh spermatozoa in ICSI were significantly higher than those of frozen spermatozoa (28.8% and 34.8% vs. 16% and 22.6%), &lt;i&gt;p&lt;/i&gt;=0.025 and 0.048, respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;The study demonstrated an association between fresh sperm use and higher success rates, but it did not prove causality.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;When both fresh and frozen sperm were used, the rates of pregnancy, live birth, and overall success in ICSI were higher in fresh sperm. Additionally, younger males and females showed a greater likelihood of successful ICSI outcomes. There is a potential benefit of using fresh sperm in ICSI for this specific patient group but highlights the ","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"5544073"},"PeriodicalIF":1.3,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12623106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145550054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Divergent Survival Outcomes With Adjuvant Chemotherapy in Stage IA Ovarian Clear Cell Carcinoma: Insights From the SEER Database. 辅助化疗对IA期卵巢透明细胞癌的不同生存结果:来自SEER数据库的见解
IF 1.3 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-24 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/9983293
Luping Pan, Yuan Xiang, Jinju Guo, Wei Liu, Xia Wang

Background: This study aims to evaluate the impact of adjuvant chemotherapy on cancer-specific survival (CSS) and overall survival (OS) in patients with Stage IA ovarian clear cell carcinoma (OCCC) using data from the Surveillance, Epidemiology, and End Results (SEER) database.

Methods: We conducted a retrospective cohort study utilizing SEER data (2000-2021) to compare the prognosis of Stage IA OCCC patients who received adjuvant chemotherapy versus those who did not. Propensity score matching (PSM) was used to balance baseline characteristics between the groups. Competing risks regression and multivariate Cox regression analyses identified prognostic factors for CSS and OS.

Results: A total of 1422 Stage IA OCCC patients were identified. After PSM, 776 patients (388 in each group) were included. For patients aged ≤ 50 years, chemotherapy was linked to worse CSS (89.5% vs. 96.2%, p=0.007) and OS (89.3% vs. 95.9%, p=0.008). Conversely, in patients aged > 70 years, chemotherapy was associated with improved CSS (93.0% vs. 81.9%, p=0.038) and OS (86.0% vs. 72.4%, p=0.006). These trends remained after PSM. Multivariate analysis showed that chemotherapy had little impact on OS and CSS. Subgroup analysis further indicated that chemotherapy negatively affected CSS and OS in patients aged ≤ 50 years.

Conclusions: Adjuvant chemotherapy did not significantly improve survival outcomes in patients with Stage IA OCCC. However, its effects were age-dependent, with older patients (> 70 years) experiencing improved survival, while younger patients (≤ 50 years) exhibited worse outcomes. These findings underscore the importance of individualized treatment strategies for Stage IA OCCC.

背景:本研究旨在利用来自监测、流行病学和最终结果(SEER)数据库的数据,评估辅助化疗对IA期卵巢透明细胞癌(OCCC)患者癌症特异性生存(CSS)和总生存(OS)的影响。方法:我们利用SEER数据(2000-2021)进行了一项回顾性队列研究,比较接受辅助化疗和未接受辅助化疗的IA期OCCC患者的预后。使用倾向评分匹配(PSM)来平衡各组之间的基线特征。竞争风险回归和多变量Cox回归分析确定了CSS和OS的预后因素。结果:共发现1422例IA期OCCC患者。PSM后共纳入776例患者(每组388例)。对于年龄≤50岁的患者,化疗与恶化的CSS(89.5%比96.2%,p=0.007)和OS(89.3%比95.9%,p=0.008)相关。相反,在bb0 ~ 70岁的患者中,化疗与改善的CSS(93.0%比81.9%,p=0.038)和OS(86.0%比72.4%,p=0.006)相关。这些趋势在PSM之后仍然存在。多因素分析显示化疗对OS和CSS影响不大。亚组分析进一步表明,化疗对年龄≤50岁患者的CSS和OS有负面影响。结论:辅助化疗不能显著改善IA期OCCC患者的生存结局。然而,其效果是年龄依赖性的,老年患者(70岁以下)的生存率提高,而年轻患者(≤50岁)的预后较差。这些发现强调了IA期OCCC个体化治疗策略的重要性。
{"title":"Divergent Survival Outcomes With Adjuvant Chemotherapy in Stage IA Ovarian Clear Cell Carcinoma: Insights From the SEER Database.","authors":"Luping Pan, Yuan Xiang, Jinju Guo, Wei Liu, Xia Wang","doi":"10.1155/ogi/9983293","DOIUrl":"10.1155/ogi/9983293","url":null,"abstract":"<p><strong>Background: </strong>This study aims to evaluate the impact of adjuvant chemotherapy on cancer-specific survival (CSS) and overall survival (OS) in patients with Stage IA ovarian clear cell carcinoma (OCCC) using data from the Surveillance, Epidemiology, and End Results (SEER) database.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study utilizing SEER data (2000-2021) to compare the prognosis of Stage IA OCCC patients who received adjuvant chemotherapy versus those who did not. Propensity score matching (PSM) was used to balance baseline characteristics between the groups. Competing risks regression and multivariate Cox regression analyses identified prognostic factors for CSS and OS.</p><p><strong>Results: </strong>A total of 1422 Stage IA OCCC patients were identified. After PSM, 776 patients (388 in each group) were included. For patients aged ≤ 50 years, chemotherapy was linked to worse CSS (89.5% vs. 96.2%, <i>p</i>=0.007) and OS (89.3% vs. 95.9%, <i>p</i>=0.008). Conversely, in patients aged > 70 years, chemotherapy was associated with improved CSS (93.0% vs. 81.9%, <i>p</i>=0.038) and OS (86.0% vs. 72.4%, <i>p</i>=0.006). These trends remained after PSM. Multivariate analysis showed that chemotherapy had little impact on OS and CSS. Subgroup analysis further indicated that chemotherapy negatively affected CSS and OS in patients aged ≤ 50 years.</p><p><strong>Conclusions: </strong>Adjuvant chemotherapy did not significantly improve survival outcomes in patients with Stage IA OCCC. However, its effects were age-dependent, with older patients (> 70 years) experiencing improved survival, while younger patients (≤ 50 years) exhibited worse outcomes. These findings underscore the importance of individualized treatment strategies for Stage IA OCCC.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"9983293"},"PeriodicalIF":1.3,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12578555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145431738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obstetrics and Gynecology International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1